Aralez Pharmaceuticals Inc (TSE:ARZ) insider Scott J. Charles sold 10,804 shares of the firm’s stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of C$1.25, for a total value of C$13,505.00.
Shares of Aralez Pharmaceuticals Inc (ARZ) opened at 1.45 on Tuesday. The stock has a 50 day moving average price of $1.71 and a 200-day moving average price of $3.03. The firm’s market capitalization is $95.48 million. Aralez Pharmaceuticals Inc has a 52 week low of $1.45 and a 52 week high of $8.75.
COPYRIGHT VIOLATION NOTICE: “Aralez Pharmaceuticals Inc (TSE:ARZ) Insider Sells C$13,505.00 in Stock” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2017/08/08/insider-selling-aralez-pharmaceuticals-inc-tsearz-insider-sells-10804-shares-of-stock-updated.html.
Several analysts have commented on ARZ shares. Chardan Capital reissued a “buy” rating on shares of Aralez Pharmaceuticals in a report on Wednesday, May 17th. Bloom Burton raised Aralez Pharmaceuticals from an “accumulate” rating to a “buy” rating in a report on Monday, April 10th.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
